About this Journal Submit a Manuscript Table of Contents
ISRN Obstetrics and Gynecology
Volume 2012 (2012), Article ID 389539, 5 pages
http://dx.doi.org/10.5402/2012/389539
Research Article

Epicardial Fat Tissue Thickness in Preeclamptic and Normal Pregnancies

1Cardiology Department, Bagcılar Research and Education Hospital, Istanbul, Turkey
2Gynecology and Obstetrics Department, Malatya Akcadag State Hospital, Istanbul, Turkey
3Cardilogy Department, Yeditepe University, Istanbul, Turkey

Received 22 August 2012; Accepted 12 September 2012

Academic Editors: A. Canellada and D. Schust

Copyright © 2012 Mehmet Mustafa Can et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Turner, “Diagnosis and management of pre-eclampsia: an update,” International Journal of Women's Health, vol. 2, no. 1, pp. 327–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Gastaldelli and G. Basta, “Ectopic fat and cardiovascular disease: what is the link?” Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 7, pp. 481–490, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Iacobellis, D. Corradi, and A. M. Sharma, “Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart,” Nature Clinical Practice Cardiovascular Medicine, vol. 2, no. 10, pp. 536–543, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. ACOG Practice Bulletin, “Diagnosis and management of preeclampsia and eclampsia. American college of obstetricians and gynecologists,” International Journal of Gynecology & Obstetrics, vol. 77, no. 1, pp. 67–75, 2002. View at Publisher · View at Google Scholar
  5. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Scopus
  6. D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Scopus
  7. W. L. Henry, A. DeMaria, and R. Gramiak, “Report of the American society of echocardiography committee on nomenclature and standards in two-dimensional echocardiography,” Circulation, vol. 62, no. 2, pp. 212–217, 1980. View at Scopus
  8. R. B. Devereux and N. Reichek, “Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method,” Circulation, vol. 55, no. 4, pp. 613–618, 1977. View at Scopus
  9. G. Iacobellis, M. C. Ribaudo, F. Assael et al., “Echocardiographic epicardial adipose tissueis related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5163–5168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Lu, Y. Y. Zhao, J. Qiao, H. J. Zhang, L. Ge, and Y. Wei, “A follow-up study of women with a history of severe preeclampsia: relationship between metabolic syndrome and preeclampsia,” Chinese Medical Journal, vol. 124, no. 5, pp. 775–779, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Nakazato, D. Dey, V. Y. Cheng et al., “Epicardial fat volume and concurrent presence of both myocardial ischemia and obstructive coronary artery disease,” Atherosclerosis, vol. 221, no. 2, pp. 422–426, 2012. View at Publisher · View at Google Scholar
  12. G. Huang, D. Wang, I. Zeb et al., “Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS),” Atherosclerosis, vol. 221, no. 1, pp. 198–205, 2012. View at Publisher · View at Google Scholar
  13. A. Yerramasu, D. Dey, S. Venuraju et al., “Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis,” Atherosclerosis, vol. 220, no. 1, pp. 223–230, 2012. View at Publisher · View at Google Scholar
  14. C. Sengul, C. Cevik, O. Ozveren et al., “Echocardiographic epicardial fat thickness is associated with carotid intima-media thickness in patients with metabolic syndrome,” Echocardiography, vol. 288, no. 8, pp. 853–858, 2011.
  15. G. Iacobellis and G. Barbaro, “The double role of epicardial adipose tissue as pro- and anti-inflammatory organ,” Hormone and Metabolic Research, vol. 40, no. 7, pp. 442–445, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. O. M. Reslan and R. A. Khalil, “Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia,” Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 8, no. 4, pp. 204–226, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Lamarca, “The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia,” Minerva Ginecologica, vol. 62, no. 2, pp. 105–120, 2010. View at Scopus
  18. E. Laresgoiti-Servitje, N. Gómez-lópez, and D. M. Olson, “An immunological insight into the origins of pre-eclampsia,” Human Reproduction Update, vol. 16, no. 5, Article ID dmq007, pp. 510–524, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. W. G. Redman, G. P. Sacks, and I. L. Sargent, “Preeclampsia: an excessive maternal inflammatory response to pregnancy,” American Journal of Obstetrics and Gynecology, vol. 180, no. 2, pp. 499–506, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Aydin, A. Toprak, O. Deyneli et al., “Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome,” Metabolic Syndrome and Related Disorders, vol. 8, no. 3, pp. 229–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Teijeira-Fernandez, S. Eiras, L. Grigorian-Shamagian, A. Fernandez, B. Adrio, and J. R. Gonzalez-Juanatey, “Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension,” Journal of Human Hypertension, vol. 22, no. 12, pp. 856–863, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. W. C. Tsai, C. C. Lin, J. Y. Chen et al., “Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension,” Blood Pressure, vol. 17, no. 4, pp. 233–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Gaborit, F. Kober, A. Jacquier et al., “Epicardial fat volume is associated with coronary microvascular response in healthy subjects: a pilot study,” Obesity, vol. 20, no. 6, pp. 1200–1205, 2012. View at Publisher · View at Google Scholar
  24. G. Paolisso, D. Manzella, M. R. Rizzo, E. Ragno, M. Barbieri, and G. Varrichio, “Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects,” American Journal of Clinical Nutrition, vol. 72, no. 3, pp. 723–730, 2000. View at Scopus
  25. A. M. Sironi, A. Gastaldelli, A. Mari et al., “Visceral fat in hypertension: influence on insulin resistance and β-cell function,” Hypertension, vol. 44, no. 2, pp. 127–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Sironi, A. Pingitore, S. Ghione et al., “Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat,” Hypertension, vol. 51, no. 2, pp. 282–288, 2008. View at Publisher · View at Google Scholar · View at Scopus